Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned
Cancer Research and Treatment. 2015;47(4):549-554 
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients
Cancer Treatment Reviews. 2013;39(8):839-850
Epidermal growth factor receptor (EGFR) in non small cell lung cancer (NSCLC)
Lung Cancer. 1994;11:2
Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices
Clinics. 2012;67(11):1349
Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation: Response to Chemotherapy
Chest. 2014;146(4):591A
Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
Pulmonary Adenocarcinoma: Approaches to Treatment. 2019;115-131
Biologically Targeted Treatment of Non–Small-Cell Lung Cancer: Focus on Epidermal Growth Factor Receptor
Clinical Lung Cancer. 2003;5:S11-S17
22 Epidermal growth factor receptor (EGFR) mutation testing in non small cell lung cancer – the New Cross Hospital experience
Lung Cancer. 2013;79:S8
Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer
Lung Cancer. 2013;80(2):191-196
The Role of Mutation Status of the Epidermal Growth Factor Receptor Gene In Advanced Non–Small Cell Lung Cancer
Medicina. 2012;48(4):25